Asymptomatic brain lesions following laserballoon-based pulmonary vein isolation

Europace

Volumn 16, Issue 2, 2014, Pages 214-219

  Wissner, Erik ^a   Metzner, Andreas ^a   Neuzil, Petr ^b   Petru, Jan ^b   Skoda, Jan ^b   Sediva, Lucia ^b   Kivelitz, Dietmar ^a   Wohlmuth, Peter ^a   Weichet, Jiri ^b   Schoonderwoerd, Bas ^a   Rausch, Peter ^a   Bardyszewski, Aleksander ^a   Tilz, Roland R ^a   Ouyang, Feifan ^a   Reddy, Vivek Y ^c   Kuck, Karl Heinz ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Brain lesion; Catheter ablation; Cryoballoon; Laserballoon; Magnetic resonance imaging

Indexed keywords

ACTIVATED CLOTTING TIME; ADULT; AGED; ARTERY DIAMETER; ARTICLE; ASYMPTOMATIC DISEASE; ATRIUM DIAMETER; BLOOD CLOTTING TIME; BRAIN DAMAGE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CATHETER SHEATH; CHADS2 SCORE; CONTROLLED STUDY; CRYOBALLOON; DIPLOPIA; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; INCIDENCE; IRRIGATED RADIOFREQUENCY; LASERBALLOON; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; MIDDLE AGED; NERVE PARALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPERATION DURATION; PHRENIC NERVE; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; VASCULAR ACCESS; VASCULAR EQUIPMENT;

ATRIAL FIBRILLATION; BRAIN LESION; CATHETER ABLATION; CRYOBALLOON; LASERBALLOON; MAGNETIC RESONANCE IMAGING;

AGED; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; CATHETER ABLATION; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CRYOSURGERY; FEMALE; HUMANS; LASER THERAPY; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; PULMONARY VEINS; RISK FACTORS; THERAPEUTIC IRRIGATION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84893244090     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut250     Document Type: Article

References (14)

1. Metzner A, Wissner E, Schmidt B, Chun KRJ, Hindricks G, Piorkowski C et al. Acute and long-term clinical outcome after endoscopic pulmonary vein isolation: results from the first prospective, multicenter study. J Cardiovasc Electrophysiol 2013;24: 7-13.
2. Ouyang F, Tilz RR, Chun KRJ, Schmidt B, Wissner E, Zerm T et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010;122:2368-77.
3. Dukkipati SR, Neuzil P, Skoda J, Petru J, d'Avila A, Doshi SK et al. Visual balloonguided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation. Circ Arrhythm Electrophysiol 2010;3:266-73.
4. Gaita F, Caponi D, Pianelli M, Scaglione M, Toso E, Cesarani F et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation 2010;122:1667-73.
5. Herrera Siklody C, Deneke T, Hocini M, Lehrmann H, Shin DI, Miyazaki S et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol 2011;58:681-8.
6. Rillig A, Meyerfeldt U, Tilz RR, Talazko J, Arya A, Zvereva V et al. Incidence and longterm follow-up of silent cerebral lesions after pulmonary vein isolation using a remote robotic navigation system as compared with manual ablation. Circ Arrhythm Electrophysiol 2012;5:15-21.
7. Martinek M, Sigmund E, Lemes C, Derndorfer M, Aichinger J, Winter S et al. Asymptomatic cerebral lesions during pulmonary vein isolation under uninterrupted oral anticoagulation. Europace 2013;15:325-31.
8. Chun KRJ, Schmidt B, Metzner A, Tilz R, Zerm T, Kö ster I et al. The 'single big cryoballoon' technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J 2009; 30:699-709.
9. Patel D, Bailey SM, Furlan AJ, Ching M, Zachaib J, Di Biase L et al. Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21:412-7.
10. Cappato R, Calkins H, Chen SA, Davies W., Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
11. Lickfett L, Hackenbroch M, Lewalter T, Selbach S, Schwab JO, Yang A et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol 2006;17:1-7.
12. Metzner A, Schmidt B, Fuernkranz A, Wissner E, Tilz RR, Koester I et al. Esophageal temperature change and esophageal thermal lesions after pulmonary vein isolation using the novel endoscopic ablation system. Heart Rhythm 2011;8:815-20.
13. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348:1215-22.
14. Verma A, Boersma L, Deneke T, Nardi S, Debruyne P, De Greef Y et al. Evaluation of reduction of asymptomatic cerebral embolism (ERACE): an international, multicenter prospective study. Heart Rhythm 2013;10:S387.